Securities code: Shanghai Junshi Biosciences Co.Ltd(688180) securities abbreviation: Shanghai Junshi Biosciences Co.Ltd(688180) Announcement No.: pro 2022032 Shanghai Junshi Biosciences Co.Ltd(688180)
Suggestive announcement on relevant precautions for attending the first extraordinary general meeting of shareholders in 2022 during epidemic prevention and control
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Junshi Biosciences Co.Ltd(688180) (hereinafter referred to as “the company”) was posted on the website of Shanghai Stock Exchange on March 8, 2022（ http://www.sse.com.cn. ）The notice of Shanghai Shanghai Junshi Biosciences Co.Ltd(688180) Pharmaceutical Technology Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2022 (Announcement No.: pro 2022015) was disclosed. The first extraordinary general meeting of shareholders in 2022 (hereinafter referred to as “the general meeting of shareholders”) is scheduled to be held on April 6, 2022 at floor 15, building 7, No. 6, Lane 100, pingjiaqiao Road, Pudong New Area, Shanghai, The general meeting of shareholders is held by combining on-site meeting and online voting.
As Shanghai is currently in the New Coronavirus epidemic prevention and control period, according to the government department’s epidemic prevention and control requirements, the shareholders’ meeting held a closed area management. In order to strictly implement the relevant requirements of epidemic prevention and control, maximize the health and safety of shareholders, shareholders’ agents and other participants, and protect the legitimate rights and interests of shareholders according to law, the company has adjusted the relevant matters of attending the general meeting of shareholders during the epidemic prevention and control period. The special tips are as follows:
1、 It is suggested that A-share shareholders give priority to online voting to participate in the general meeting of shareholders
In order to cooperate with the epidemic prevention and control work, protect the health of shareholders, shareholders’ agents and other participants, reduce personnel aggregation and reduce the risk of infection, it is suggested that A-share shareholders give priority to participating in the shareholders’ meeting through online voting.
2、 Adjust the on-site meeting to be held by means of communication
Based on the requirements of epidemic prevention and control and in combination with the relevant regulatory policies of Shanghai Stock Exchange, this shareholders’ meeting was held by means of communication, and no on-site meeting was set up. Shareholders of A-Shares who wish to participate in the meeting by means of communication must send email to the company 48 hours before the shareholders’ meeting (i.e. before 2:00 p.m. on April 4, 2022) (email address: [email protected]. ）For registration, the information to be provided and presented by the shareholders attending the meeting by means of communication is consistent with the requirements of attending the on-site meeting. The shareholders and shareholders’ agents who fail to complete the registration before the deadline for registration will not be able to access the general meeting of shareholders by means of communication, but can still participate in the general meeting of shareholders by means of online voting. The company will provide the shareholders and their agents who have successfully registered with the company with access to the meeting by means of communication. Please do not share the access information with other third parties.
The convening time, equity registration date, deliberation items and other matters of the general meeting of shareholders remain unchanged.
It is hereby announced.
Shanghai Junshi Biosciences Co.Ltd(688180) board of directors April 2, 2022
